CoChat

Simultaneous measurement of excitation-contraction coupling parameters identifies mechanisms underlying contractile responses of hiPSC-derived cardiomyocytes

Open access
van Meer, Berend J., Krotenberg, Ana, Sala, Luca, Davis, Richard P., Eschenhagen, Thomas, Denning, Chris, Tertoolen, Leon G. J., Mummery, Christine L. · 2019 · Nature Communications
Cited by 73

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

Cardiomyocytes from human induced pluripotent stem cells (hiPSC-CMs) are increasingly recognized as valuable for determining the effects of drugs on ion channels but they do not always accurately predict contractile responses of the human heart. This is in part attributable to their immaturity but the sensitivity of measurement tools may also be limiting. Measuring action potential, calcium flux or contraction individually misses critical information that is captured when interrogating the complete excitation-contraction coupling cascade simultaneously. Here, we develop an hypothesis-based statistical algorithm that identifies mechanisms of action. We design and build a high-speed optical system to measure action potential, cytosolic calcium and contraction simultaneously using fluorescent sensors. These measurements are automatically processed, quantified and then assessed by the algorithm. Multiplexing these three critical physical features of hiPSC-CMs allows identification of all major drug classes affecting contractility with detection sensitivities higher than individual measurement of action potential, cytosolic calcium or contraction.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-019-12354-8

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 52

  1. Braam, S. R. et al. Prediction of drug-induced cardiotoxicity using human embryonic stem cell-derived cardiomyocytes. Stem Cell Res. 4, 107–116 (2010). · DOI · Paper page
  2. Blinova, K. et al. Comprehensive translational assessment of human induced pluripotent stem cell derived cardiomyocytes for evaluating drug-induced arrhythmias. Toxicol. Sci. 155, 234–247 (2016). · DOI · Paper page
  3. Colatsky, T. et al. The Comprehensive in Vitro Proarrhythmia Assay (CiPA) initiative—Update on progress. J. Pharmacol. Toxicol. Methods 81, 15–20 (2016). · DOI · Paper page
  4. Redfern, W. S. et al. Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: Evidence for a provisional safety margin in drug development. Cardiovasc. Res. 58, 32–45 (2003). · DOI · Paper page
  5. Pointon, A. et al. Assessment of cardiomyocyte contraction in human-induced pluripotent stem cell-derived cardiomyocytes. Toxicol. Sci. 144, 227–237 (2014). · DOI · Paper page
  6. Bers, D. M. Cardiac excitation-contraction coupling. Nature 415, 198–205 (2002). · DOI · Paper page
  7. Birket, M. J. et al. Contractile defect caused by mutation in MYBPC3 revealed under conditions optimized for human PSC-cardiomyocyte function. Cell Rep. 13, 733–745 (2015). · DOI · Paper page
  8. Giacomelli, E. et al. Three-dimensional cardiac microtissues composed of cardiomyocytes and endothelial cells co-differentiated from human pluripotent stem cells. Development 144, 1008–1017 (2017). · DOI · Paper page
  9. Pointon, A. et al. High-throughput imaging of cardiac microtissues for the assessment of cardiac contraction during drug discovery. Toxicol. Sci. 155, 444–457 (2016). · DOI · Paper page
  10. Mannhardt, I. et al. Human engineered heart tissue: analysis of contractile force. Stem Cell Rep. 7, 29–42 (2016). · DOI · Paper page
  11. van Meer, B. J., Tertoolen, L. G. J. & Mummery, C. L. Concise review: measuring physiological responses of human pluripotent stem cell derived cardiomyocytes to drugs and disease. Stem Cells 34, 2008–2015 (2016). · DOI · Paper page
  12. Ravens, U., Wettwer, E., Pfeifer, T., Himmel, H. & Armah, B. Characterization of the effects of the new inotropic agent BDF 9148 in isolated papillary muscles and myocytes of the guinea‐pig heart. Br. J. Pharmacol. 104, 1019–1023 (1991). · doi:10.1111/j.1476-5381.1991.tb12543.x
  13. Thomas, G., Chung, M. & Cohen, C. J. A dihydropyridine (Bay k 8644) that enhances calcium currents in guinea pig and calf myocardial cells. A new type of positive inotropic agent. Circ. Res. 56, 87–96 (1985). · doi:10.1161/01.res.56.1.87
  14. Fuerstenwerth, H. On the differences between ouabain and digitalis glycosides. Am. J. Ther. 21, 35–42 (2014). · DOI
  15. Cui, X.-L., Zhao, L.-Y. & Wu, B.-W. E-4031 enhanced Ca2+ transient and ventricular myocytes contraction via reverse mode Na+/Ca2+ exchange in normal and hypertrophic rats. Acta Pharmacol. Sin. 23, 797–802 (2002).
  16. Planelles-Herrero, V. J., Hartman, J. J., Robert-Paganin, J., Malik, F. I. & Houdusse, A. Mechanistic and structural basis for activation of cardiac myosin force production by omecamtiv mecarbil. Nat. Commun. 8, 190 (2017). · DOI · Paper page
  17. Lohse, M. J., Engelhardt, S. & Eschenhagen, T. What is the role of beta-adrenergic signaling in heart failure? Circ. Res. 93, 896–906 (2003). · DOI · Paper page
  18. Knight, W. & Yan, C. Therapeutic potential of PDE modulation in treating heart disease. Future Med. Chem. 5, 1607–1620 (2013). · doi:10.4155/fmc.13.127
  19. Itzhaki, I. et al. Calcium handling in human induced pluripotent stem cell derived cardiomyocytes. PLoS One 6, e18037 (2011). · DOI · Paper page
  20. Zhao, L. & Zhang, B. Doxorubicin induces cardiotoxicity through upregulation of death receptors mediated apoptosis in cardiomyocytes. Sci. Rep. 7, 1–11 (2017). · DOI · Paper page
  21. Brack, K. E., Narang, R., Winter, J. & Andr, G. The mechanical uncoupler blebbistatin is associated with significant electrophysiological effects in the isolated rabbit heart. Exp. Physiol. 98, 1009–1027 (2013). · doi:10.1113/expphysiol.2012.069369
  22. Guo, L. et al. The electrophysiological effects of cardiac glycosides in cardiomyocytes and in guinea pig isolated hearts. Cell. Physiol. Biochem. 27, 453–462 (2011). · DOI
  23. Abrahamsson, C., Duker, G., Lundberg, C. & Carlsson, L. Electrophysiological and inotropic effects of H 234/09 (almokalant) in vitro: a comparison with two other novel IK blocking drugs, UK-68,798 (dofetilide) and E-4031. Cardiovasc. Res. 27, 861–867 (1993). · doi:10.1093/cvr/27.5.861
  24. Cherry, E. M. & Fenton, F. H. Suppression of alternans and conduction blocks despite steep APD restitution: electrotonic, memory, and conduction velocity restitution effects. Am. J. Physiol. Circ. Physiol. 286, H2332–H2341 (2004). · DOI · Paper page
  25. Zhang, M. et al. Recessive cardiac phenotypes in induced pluripotent stem cell models of Jervell and Lange-Nielsen syndrome: Disease mechanisms and pharmacological rescue. Proc. Natl Acad. Sci. USA 111, E5383–E5392 (2014). · DOI · Paper page
  26. Sala, L. et al. A new hERG allosteric modulator rescues genetic and drug‐induced long‐QT syndrome phenotypes in cardiomyocytes from isogenic pairs of patient induced pluripotent stem cells. EMBO Mol. Med. 8, 1065–1081 (2016). · DOI · Paper page
  27. Knisley, S. B., Justice, R. K., Kong, W. & Johnson, P. L. Ratiometry of transmembrane voltage-sensitive fluorescent dye emission in hearts. Am. J. Physiol. Circ. Physiol. 279, H1421–H1433 (2000). · DOI
  28. Uzelac, I. & Fenton, F. H. Robust framework for quantitative analysis of optical mapping signals without filtering. in 2015 Computing in Cardiology Conference (CinC), Nice. 461–464 (IEEE, 2015). · doi:10.1109/cic.2015.7408686
  29. Bohm, M. et al. Contribution of cAMP-phosphodiesterase inhibition and sensitization of the contractile proteins for calcium to the inotropic effect of pimobendan in the failing human myocardium. Circ. Res. 68, 689–701 (1991). · DOI · Paper page
  30. Abi-Gerges, N. et al. Preservation of cardiomyocytes from the adult heart. J. Mol. Cell. Cardiol. 64, 108–119 (2013). · DOI
  31. Watanabe, H., Honda, Y., Deguchi, J., Yamada, T. & Bando, K. Usefulness of cardiotoxicity assessment using calcium transient in human induced pluripotent stem cell-derived cardiomyocytes. J. Toxicol. Sci. 42, 519–527 (2017). · DOI
  32. Mewes, T., Dutz, S., Ravens, U. & Jakobs, K. H. Activation of calcium currents in cardiac myocytes by empty β- adrenoceptors. Circulation 88, 2916–2922 (1993). · DOI
  33. Klimas, A. et al. Multimodal on-axis platform for all-optical electrophysiology with near-infrared probes in human stem-cell-derived cardiomyocytes. bioRxiv 10776, 10767–10776 (2018).
  34. Hortigon-Vinagre, M. P. et al. The use of ratiometric fluorescence measurements of the voltage sensitive dye Di-4-ANEPPS to examine action potential characteristics and drug effects on human induced pluripotent stem cell-derived cardiomyocytes. Toxicol. Sci. 154, 320–331 (2016). · DOI
  35. Christoph, J. et al. Electromechanical vortex filaments during cardiac fibrillation. Nature 555, 667–672 (2018). · DOI · Paper page
  36. Ruan, J.-L. et al. Mechanical Stress promotes maturation of human myocardium from pluripotent stem cell-derived progenitors. Stem Cells 33, 2148–2157 (2015). · DOI · Paper page
  37. Lemoine, M. D. et al. Human iPSC-derived cardiomyocytes cultured in 3D engineered heart tissue show physiological upstroke velocity and sodium current density. Sci. Rep. 7, 5464 (2017). · DOI · Paper page
  38. Sala, L., Ward-van Oostwaard, D., Tertoolen, L. G. J., Mummery, C. L. & Bellin, M. Electrophysiological analysis of human pluripotent stem cell-derived cardiomyocytes (hPSC-CMs) using multi-electrode arrays (MEAs). J. Vis. Exp. e55587 (2017). · DOI
  39. Guo, L. et al. Estimating the risk of drug-induced proarrhythmia using human induced pluripotent stem cell–derived cardiomyocytes. Toxicol. Sci. 123, 281–289 (2011). · DOI · Paper page
  40. Clements, M., Millar, V., Williams, A. S. & Kalinka, S. Bridging functional and structural cardiotoxicity assays using human embryonic stem cell-derived cardiomyocytes for a more comprehensive risk assessment. Toxicol. Sci. 148, 241–260 (2015). · DOI
  41. Maddah, M. et al. A non-invasive platform for functional characterization of stem-cell-derived cardiomyocytes with applications in cardiotoxicity testing. Stem Cell Rep. 4, 621–631 (2015). · DOI · Paper page
  42. Fürstenwerth, H. Ouabain—the insulin of the heart. Int. J. Clin. Pract. 64, 1591–1594 (2010). · DOI
  43. Shimoni, Y., Gotsman, M., Deutsch, J., Kachalsky, S. & Lichtstein, D. Endogenous ouabain-like compound increases heart muscle contractility. Nature 307, 369–371 (1984). · DOI
  44. Cleland, J. G. F. et al. The effects of the cardiac myosin activator, omecamtiv mecarbil, on cardiac function in systolic heart failure: A double-blind, placebo-controlled, crossover, dose-ranging phase 2 trial. Lancet 378, 676–683 (2011). · DOI · Paper page
  45. Horváth, B. et al. Frequency-dependent effects of omecamtiv mecarbil on cell shortening of isolated canine ventricular cardiomyocytes. Naunyn. Schmiedebergs. Arch. Pharmacol. 390, 1239–1246 (2017). · DOI
  46. Reyes, G., Schwartz, P. H., Newth, C. J. & Eldadah, M. K. The pharmacokinetics of isoproterenol in critically ill pediatric patients. J. Clin. Pharmacol. 33, 29–34 (1993). · DOI
  47. Molenaar, P. et al. (-)-Adrenaline elicits positive inotropic, lusitropic, and biochemical effects through β2-adrenoceptors in human atrial myocardium from nonfailing and failing hearts, consistent with Gs coupling but not with Gi coupling. Naunyn. Schmiedebergs. Arch. Pharmacol. 375, 11–28 (2007). · DOI
  48. Singh, B. N., Ellrodt, G. & Peter, C. T. Verapamil: a review of its pharmacological properties and therapeutic use. Drugs 15, 169–197 (1978). · DOI · Paper page
  49. Angus, J. A., Sarsero, D., Fujiwara, T., Molenaar, P. & Xi, Q. Quantitative analysis of vascular to cardiac selectivity of L- and T-type voltage-operated calcium channel antagonists in human tissues. Clin. Exp. Pharmacol. Physiol. 27, 1019–1021 (2000). · doi:10.1046/j.1440-1681.2000.03369.x
  50. Giacomini, K. M., Massoud, N., Wong, F. M. & Giacomini, J. C. Decreased binding of verapamil to plasma proteins in patients with liver disease. J. Cardiovasc. Pharmacol. 6, 924–928 (1984). · doi:10.1097/00005344-198409000-00028
  51. Hanna, A. D., Lam, A., Tham, S., Dulhunty, A. F. & Beard, N. A. Adverse effects of doxorubicin and its metabolic product on cardiac RyR2 and SERCA2A. Mol. Pharmacol. 86, 438–449 (2014). · DOI · Paper page
  52. Temma, K. et al. Comparison of cardiac actions of doxorubicin, pirarubicin and aclarubicin in isolated guinea-pig heart. Eur. J. Pharmacol. 234, 173–181 (1993). · doi:10.1016/0014-2999(93)90951-d

Cited by

See all 73

Metadata

Authors
van Meer, B. J., Krotenberg, A., Sala, L., Davis, R. P., Eschenhagen, T., Denning, C., Tertoolen, L. G. J., & Mummery, C. L.
Venue
Nature Communications
Published
2019-09-20
Volume
10
Issue
1
Pages
4325-4325
ISSN
2041-1723 (ISSN-L)
OpenAlex
W2973232024
Cited by
73
References
3
FWCI
6.03
Type
journal article
Language
en
Open access
gold
Licence
Funders
  • National Centre for the Replacement Refinement and Reduction of Animals in Research (NC/K000225/1)
  • British Heart Foundation (SP/15/9/31605, RG/15/6/31436, PG/14/59/31000, RG/14/1/30588, P47352)
  • RCUK | Medical Research Council (MR/M017354/1, G0801098)
  • Heart Research UK (TRP01/12)
  • Nederlandse Organisatie voor Wetenschappelijk Onderzoek (024.003.001)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Simultaneous measurement of excitation-contraction coupling parameters identifies mechanisms underlying contractile responses of hiPSC-derived cardiomyocytes. https://app.cochat.ai/papers/10.1038/s41467-019-12354-8
The paper
van Meer, B. J., Krotenberg, A., Sala, L., Davis, R. P., Eschenhagen, T., Denning, C., Tertoolen, L. G. J., & Mummery, C. L. (2019). Simultaneous measurement of excitation-contraction coupling parameters identifies mechanisms underlying contractile responses of hiPSC-derived cardiomyocytes. Nature Communications. https://doi.org/10.1038/s41467-019-12354-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.